Discovery
Landmark Bio picks up USD 18.3m ARPA-H award for extracellular vesicle manufacturing platform
Watertown, Mass.-based Landmark Bio has secured an ARPA-H award of up to USD 18.3 million to develop a continuous manufacturing platform for extracellular...
Lancet: Chia Tai's benmelstobart and anlotinib combo outperforms pembrolizumab in lung cancer trial
Researchers across 79 centres in China report that benmelstobart anlotinib lung cancer combination therapy produced statistically significant improvements...
Novomedix wins $2.98 million NCI contract to advance oral drug for pediatric solid tumors
Novomedix, a San Diego-based for-profit company, has received a $2.98 million SBIR Phase II contract from the National Cancer Institute to advance a...
Sinopia Biosciences receives NCI grant to apply LEADS metabolomics platform to oncology drug discovery
Sinopia Biosciences, a privately held biotechnology company headquartered at JLABS San Diego, announced in March 2026 that it has been awarded a research...
University of Toronto researchers show reengineered long noncoding RNAs reduce inflammation in macrophages and mice
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) in Toronto, Canada, report that naturally occurring long noncoding...
Researchers report first in vivo CAR-T cell generation in multiple myeloma patients using ESO-T01 vector
Investigators in China report that a single intravenous infusion of ESO-T01, a nanobody-directed lentiviral vector, generated functional anti-BCMA CAR-T...
The AllSci Brief
Systematic R&D and deal news. Daily.